Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01767818 · ClinicalTrials.gov registry record
Parkinson's Disease Biomarker Program
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 238
- Enrollment target
NCT01767818 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 238 participants.
The verdict
NCT01767818 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 238 participants
- Enrollment target
Study Summary
The primary objective of this study is to obtain detailed clinical information and biologic specimens from subjects with PD toward the ultimate end of identifying a biomarker of PD. Because of the inherent difficulties of using clinical outcome measures to assess disease modification, the identification of biomarkers of PD is of paramount importance. The ideal PD biomarker would be one that is easily assayed in a convenient biological sample, varies proportionally with disease severity, is abnormal during the pre-symptomatic phase of the illness, and is unaffected by drugs or other interventions used to treat PD. The existence of a sensitive biomarker with these properties would enable much more effective disease modifying research that would likely be able to take advantage of smaller and potentially shorter trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01767818
The ClinicalTrials.gov registry entry for NCT01767818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01767818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01767818 about?
NCT01767818 is a clinical study titled "Parkinson's Disease Biomarker Program". The primary objective of this study is to obtain detailed clinical information and biologic specimens from subjects with PD toward the ultimate end of identifying a biomarker of PD. Because of the inherent difficulties of using clinical outcome measures to assess disease modification, the identifica...
What is the current status of trial NCT01767818?
This trial is currently completed. The enrollment target is 238 participants. The study started on 2012-11. Estimated completion is 2017-09-30.
Who is sponsoring clinical trial NCT01767818?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.